Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Rate Of Release And Retentivity Of Prostaglandin E1 In Lipid Emulsion.

T. Yamaguchi, Y. Fukushima, S. Itai, H. Hayashi
Published 1995 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
The rates of release of prostaglandin E1 (PGE1) from lipid particles into aqueous solution were obtained by the dialysis method, for parenteral lipid emulsion (Lipo-PGE1) diluted 10-times with buffered solutions of various pH. The findings, which were the rates of release of PGE1, were used to calculate the amount of PGE1 distributed in lipid particles when Lipo-PGE1, diluted 100-times with various pH levels of the buffered solution, was administered by intravenous drip infusion. More than 90% of PGE1 was retained in the lipid particles and intravenously infused when transfusion fluid pH was less than 5.5 and 2 ml of Lipo-PGE1 and 198 ml of transfusion fluid had been mixed and were administered over 2 h. Results from simulation showed that half of the PGE1 was retained in lipid particles and was infused, if Lipo-PGE1 was diluted 100-times with pH 8 transfusion fluid. Though PGE1 was sparingly soluble in an aqueous solution, these findings demonstrated that a significant amount of PGE1 was retained in lipid particles. Thus, this dosage form is expected to be highly effective for a drug delivery of PGE1 in clinical treatment.
This paper references

This paper is referenced by
Association and release of prostaglandin E1 from liposomes.
S. M. Davidson (1997)
Pharmaceutical quality evaluation of lipid emulsions containing PGE1: alteration in the number of large particles in infusion solutions.
Hiroko Shibata (2009)
Lipid microspheres as drug carriers: a pharmaceutical point of view
T. Yamaguchi (1996)
Molecular interactions between phospholipids and electrolytes in a monolayer of parenteral lipid emulsion
T. Yamaguchi (1997)
Formulation development of a filter-sterilizable lipid emulsion for lipophilic KW-3902, a newly synthesized adenosine A1-receptor antagonist.
T. Hosokawa (2002)
Luisa Bartmann Wild (2010)
Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate
H. Heiati (1997)
Emulsions as Drug Delivery Systems
K. Buszello (2000)
Surface composition regulates clearance from plasma and triolein lipolysis of lipid emulsions
I. Arimoto (1998)
Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion
Saed Abbasi (2016)
Formulation optimization of prostaglandin E1-loaded lipid emulsion: Enhanced stability and reduced biodegradation
N. Zhang (2013)
In Vivo ESR Studies on Pharmacokinetics and Metabolism of Parenteral Lipid Emulsion in Living Mice
T. Yamaguchi (2004)
Alteration of therapeutic efficacy of lipid microspheres incorporating prostaglandin E1 by mixing with aqueous solution.
Y. Komori (2007)
Coalescence of Lipid Emulsions in Floating and Freeze-Thawing Processes: Examination of the Coalescence Transition State Theory.
Saito (1999)
Solid lipid nanoparticles as drug carriers: II. Plasma stability and biodistribution of solid lipid nanoparticles containing the lipophilic prodrug 3′-azido-3′-deoxythymidine palmitate in mice
H. Heiati (1998)
The distribution and chemical kinetics of prostaglandin E1 in lipid emulsions
D. L. Teagarden (1996)
Semantic Scholar Logo Some data provided by SemanticScholar